Thymosin alpha 1 vs thymulin: compare peptide size, zinc dependence, FDA status, and human evidence so you can tell these two thymic peptides apart.
Thymosin alpha 1 and thymulin are both thymus-derived peptides studied for immune modulation, but they are distinct molecules with different sizes, mechanisms, and regulatory histories. Thymosin alpha 1 is a 28-amino-acid synthetic peptide with decades of human clinical research behind it, while thymulin is a nine-amino-acid, zinc-dependent hormone that has never been approved as a drug anywhere in the world. Neither peptide is FDA-approved for human use in the United States.
What Is Thymosin Alpha 1?
Thymosin alpha 1 is a synthetic copy of a peptide first isolated from thymosin fraction 5, a bovine thymus extract. Its pharmaceutical form is known as thymalfasin and is licensed in some countries under brand names such as Zadaxin.
The peptide binds to toll-like receptors on immune cells, which promotes dendritic cell maturation and supports T-cell and natural killer cell activity. In plain terms, it tunes the immune response rather than attacking pathogens directly.
- Approved in more than 35 countries as an adjunct therapy for chronic hepatitis B and C.
- Studied as a vaccine adjuvant and in sepsis, oncology, and immune-aging research.
- Given by subcutaneous injection; oral forms are poorly absorbed.
Research into thymosin alpha 1 benefits centers on restoring immune balance in people whose immune function is suppressed or dysregulated. It is an immune modulator, not an antibiotic or a direct antiviral.
What Is Thymulin?
Thymulin, also called serum thymic factor or FTS, is a nonapeptide produced by thymic epithelial cells. Its defining feature is that it must bind zinc to become biologically active — without zinc in the molecule, thymulin does not function.
Thymulin helps regulate T-cell differentiation and cytokine balance. Blood levels of active thymulin fall sharply with age as the thymus shrinks, which is one reason the peptide appears so often in immunosenescence research.
- Only nine amino acids long, making it one of the smallest thymic peptides studied.
- Zinc-dependent: dietary zinc status directly affects how much active thymulin circulates.
- No approved drug form; human data is limited to small, mostly older studies.
Because of the zinc connection, thymulin research overlaps more with nutritional immunology than with drug development.
Thymosin Alpha 1 vs Thymulin: Side-by-Side Comparison
| Feature | Thymosin alpha 1 | Thymulin |
|---|---|---|
| Amino acid length | 28 amino acids | 9 amino acids |
| Other names | Thymalfasin, Zadaxin | Serum thymic factor (FTS) |
| Zinc required for activity | No | Yes |
| US regulatory status | Not FDA-approved | Not FDA-approved; no approved drug form worldwide |
| Human clinical data | Extensive; licensed in 35+ countries for certain uses | Limited; mostly preclinical and small older trials |
| Primary research focus | Immune modulation, hepatitis adjunct, vaccine response, sepsis | T-cell differentiation, immune aging, zinc biology |
| Typical research route | Subcutaneous injection | Subcutaneous injection (research only) |
| Consumer availability | Sold as a research chemical | Sold as a research chemical |
The biggest practical difference is evidence volume. Thymosin alpha 1 has been given to large numbers of patients in licensed settings abroad, while thymulin has never cleared that bar.
How Thymosin Alpha 1 and Thymulin Overlap
Both peptides originate in the thymus, both are studied for immune regulation, and both are sold online as research chemicals rather than approved medicines. That overlap is why thymulin vs thymosin alpha 1 comparisons appear so often — and why they can be misleading.
- Both become less relevant as the thymus involutes with age.
- Both are used by injection in research settings, since peptides break down in the digestive tract.
- Neither has an FDA-approved human dose.
Thymulin's zinc requirement is unique among thymic peptides. No other well-known thymus peptide needs a trace mineral cofactor to work, which makes thymulin closer to a zinc-dependent hormone than a conventional immunomodulatory drug.
Related Peptides People Confuse With These Two
Several other peptides get pulled into the same conversation. The comparison thymalin vs thymosin alpha 1 is common because thymalin is a bovine thymic extract containing dozens of peptides, not a single defined molecule like thymosin alpha 1.
It also helps to separate the alpha and beta families. The contrast of thymosin alpha 1 vs thymosin beta 4 matters because beta 4 is a 43-amino-acid peptide that binds actin and is studied for wound healing and tissue repair, with almost no overlap in immune signaling.
Likewise, thymosin alpha 1 vs tb500 is not a like-for-like match. TB-500 is a synthetic fragment of thymosin beta 4, so it belongs to the tissue-repair side of peptide research rather than the immune-modulation side.
Safety, Legal Status, and Dosing
Neither thymosin alpha 1 nor thymulin is FDA-approved for human use in the United States. Both are commonly sold online as research chemicals, which means purity, sterility, and actual peptide content are not verified by any regulator.
There is no established human dosing standard for either peptide. Dosing information shared online comes from research protocols, not from approved prescribing labels, and it should not be treated as medical guidance.
Interest in thymosin alpha 1 when sick rises every cold and flu season, but no FDA-cleared product exists for that purpose and no evidence shows that self-injecting an unverified peptide is safe.
Anyone considering these peptides should speak with a healthcare professional first, especially people who are pregnant, immunocompromised, or taking immunosuppressant medication. Injection-site reactions, allergic responses, and interactions with immune drugs are all possible.
The Bottom Line
Thymosin alpha 1 and thymulin are both thymic peptides, but they differ in size, mechanism, and how much human evidence supports them. Thymosin alpha 1 is the far better studied of the two, and thymulin remains a zinc-dependent research molecule with no approved medical use.
Frequently Asked Questions
Is thymulin the same as thymosin alpha 1?
No. Thymulin is a nine-amino-acid peptide that requires zinc to be active, while thymosin alpha 1 is a 28-amino-acid synthetic peptide with no mineral cofactor. They come from the same gland but have different structures, mechanisms, and research histories.
What is thymulin used for?
Thymulin has no approved medical use anywhere in the world. It is studied in laboratory and aging research for its role in T-cell differentiation, cytokine regulation, and the decline of immune function with age. Its activity depends on adequate zinc status.
Is thymosin alpha 1 FDA-approved?
No. Thymosin alpha 1 is not FDA-approved for human use in the United States, though it is licensed in more than 35 other countries as an adjunct therapy for chronic hepatitis B and C. In the US it is sold only as a research chemical, without guaranteed purity or sterility.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.